Edition:
United States

Avenue Therapeutics Inc (ATXI.OQ)

ATXI.OQ on NASDAQ Stock Exchange Capital Market

4.50USD
10:04am EST
Change (% chg)

$0.28 (+6.64%)
Prev Close
$4.22
Open
$4.18
Day's High
$4.50
Day's Low
$4.18
Volume
168
Avg. Vol
8,512
52-wk High
$8.56
52-wk Low
$3.58

Chart for

About

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $43.42
Shares Outstanding(Mil.): 10.27
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.96 15.25
EPS (TTM): -- -- --
ROI: -- 15.07 33.27
ROE: -- 16.58 16.35

BRIEF-Avenue Therapeutics reports Q3 loss per share $0.30

* Avenue Therapeutics Inc reports third quarter 2017 financial results and recent corporate highlights

Nov 09 2017

BRIEF-Avenue therapeutics reports Q2 loss per share $0.70

* Avenue Therapeutics reports second quarter 2017 financial results and recent corporate highlights

Aug 11 2017

Earnings vs. Estimates

No consensus analysis data available.